VPF
MRK icon

Vantage Point Financial’s Merck MRK Stock Holding History

Vantage Point Financial’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
2,831
+90
+3% +$10.5K 0.11% 120
2026
Q1 		$330K Buy
2,741
+157
+6% +$18.1K 0.12% 119
2025
Q4 		$272K Buy
+2,584
New +$243K 0.1% 134

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vantage Point Financial's MRK Position: Q2 2026 in Review

Vantage Point Financial increased its Merck (MRK) stake by 3.3% in Q2 2026, buying an estimated $10.5K and bringing the position to 2,831 shares worth $364K. The position accounts for 0.11% of the portfolio, ranked #120.

Vantage Point Financial first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vantage Point Financial held 2,831 shares of Merck worth $364K as of Q2 2026.
  • Vantage Point Financial bought 90 Merck shares in Q2 2026, an estimated $10.5K.
  • Merck made up 0.11% of Vantage Point Financial's portfolio in Q2 2026, its #120 holding.
  • Vantage Point Financial first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vantage Point Financial's 13F filing for Q2 2026, filed 14 Aug 2026.